A motion sickness drug that treats severe depression in hours? Discover how scopolamine may revolutionize mental health ...

It is well-known that monoamine oxidase (MAO) plays a pivotal role in neurodegeneration and the inhibition of this enzyme can manifest antidepressant properties as well as have a positive impact in ...

DelveInsight's Epilepsy pipeline report depicts a robust space with 75+ active players working to develop 90+ pipeline ...

On the Sun Coming Out in the Afternoon. Methinks all things have traveled since you shined, But only Time and clouds, Time’s ...

The role of monoamine oxidase A (MAO-A) in the aggressiveness of prostate cancer (PCa) has been established in recent years. The molecular imaging of MAO-A expression could offer a noninvasive tool ...

Transcend Therapeutics has announced that the US Food and Drug Administration (FDA) has granted breakthrough therapy ...

If you’ve been struggling with feeling low constantly, you are not alone. Around 8.7 million people in England were prescribed an antidepressant in 2023-24 to treat their melancholy and the figures ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder (PTSD).

A Connecticut native and physical trainer who became a central figure in an inspirational video for the popular YouTuber MrBeast is being remembered for his drive, his heart, and his sense of fun. Now ...

MAXONA Pharmaceuticals announced the formation of its Scientific Advisory Board (SAB) and the successful completion of its ...

Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox ...

Zyrtec-D should not be used by people taking monoamine oxidase inhibitors (MAOIs), an older class of medications used to treat Parkinson's disease, depression, and other mental health conditions.